Track 7: Stem Cell in Cardiovascular Disease
Cardiovascular Diseases (CVD) includes congestive heart failure stroke and hypertension, coronary artery disease. Most of these diseases may occur when there is a less oxygen supply to heart cells / Cardiomyocytes which damaged as being supplied by less oxygen as well as less blood which we can treated by stem cell therapy by inducing some bone-marrow derived mononuclear cells, umbilical cord blood cells, Mesenchyme stem cells or Cardiac stem cells in to the damaged portion of heart. These cells interspersed in to heart and secrete certain portions and paracrine factors that repair of the damaged area by cardiac tissue Regeneration.
Related Conference of Track 7: Stem Cell in Cardiovascular Disease
October 27-28, 2025
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Madrid, Spain
November 17-18, 2025
18th International Conference on Human Genomics and Genomic Medicine
Paris, France
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Track 7: Stem Cell in Cardiovascular Disease Conference Speakers
Recommended Sessions
- Track 10: Cellular Therapies
- Track 11: Advanced Gene Therapeutics
- Track 12: CAR T-cell therapy
- Track 13: Cancer Therapies
- Track 14: Nano-Therapy
- Track 15: Human Gene Therapy
- Track 16: Diabetes Gene Therapy
- Track 17: Molecular Epigenetics
- Track 18: Genetic Vaccines
- Track 19: Clinical Trials and Research in Cell and Gene Therapies
- Track 1: Cell Science and Stem Cell Research
- Track 20: Skin cell therapy
- Track 21: HIV gene therapy
- Track 22: Cell Therapy in Pulmonology
- Track 2: Stem Cell Therapies
- Track 3: Cell Culture and Bioprocessing
- Track 4: Viral gene therapy
- Track 5: Stem Cell in Drug Development
- Track 6: Nanotechnology in Stem Cell
- Track 7: Stem Cell in Cardiovascular Disease
- Track 8: Novel Stem Cell Therapy
- Track 9: Stem cell engineering
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)